Prophylaxis for HSV-1 Exposure Without Rash

Recommended Antiviral Options

The Centers for Disease Control and Prevention recommends valacyclovir 1g orally twice daily for 7-10 days for prophylaxis of HSV-1 exposure without rash 1
The Centers for Disease Control and Prevention recommends acyclovir 400mg orally three times daily for 7-10 days for prophylaxis of HSV-1 exposure without rash 1
The Centers for Disease Control and Prevention recommends famciclovir 250mg orally three times daily for 7-10 days for prophylaxis of HSV-1 exposure without rash 2

Early initiation of therapy is crucial to prevent viral replication and establishment of latent infection, and treatment should begin within 72 hours of exposure for optimal effectiveness 2
Prophylaxis is particularly important for immunocompromised individuals who may experience more severe disease, and higher doses may be required, such as acyclovir 400mg orally three to five times daily until clinical resolution 3

For HIV-infected patients, higher dosages may be beneficial, such as acyclovir 400mg orally three to five times daily, and monitor for development of resistance, especially in severely immunocompromised patients 3
For pregnant women, the safety of systemic acyclovir and valacyclovir has not been fully established, but benefits may outweigh risks in certain situations, and consider reporting pregnant women receiving acyclovir or valacyclovir to the registry maintained by the CDC 3

Monitor for development of lesions or symptoms during prophylaxis period, and advise patients to report any signs of infection despite prophylaxis 1
No routine laboratory monitoring is required for short-term prophylaxis in immunocompetent patients 3

Prophylaxis does not eliminate the risk of future recurrences, and antiviral medications neither eradicate latent virus nor affect the risk, frequency, or severity of recurrences after discontinuation 1
Patients should be counseled about the natural history of HSV infection, with emphasis on potential for recurrent episodes and asymptomatic viral shedding, and sexual transmission can occur during asymptomatic periods 2